Diabetic Technology & Medication
161 articles
- A Guide to Using Digital Apps to Track and Analyze Your Ketone Data
- Understanding the FDA Approval Process for Canagliflozin
- Canagliflozin vs Other Sglt2 Inhibitors: What’s the Difference?
- Emerging Evidence on the Safety and Efficacy of New Sglt2 Inhibitors in Diverse Populations
- Emerging Data on Dual-targeting Drugs for Simultaneous Management of Hyperglycemia and Hypertension
- Openaps and the Future of Fully Automated Artificial Pancreas Systems
- Exploring the Use of Openaps in Clinical Trials and Research Settings
- Openaps and the Role of Open-source Hardware in Emergency Medical Situations
- Openaps and the Benefits of Open-source Collaboration in Medical Devices
- Integrating Openaps with Dexcom G6 for Automated Insulin Delivery
- Innovations in Inhaler Technology for Enhanced Dose Accuracy and User Comfort
- The Benefits of Personalized Medicine Approaches in Afrezza Therapy
- Addressing Challenges in Prescribing Afrezza to Patients with Respiratory Conditions
- The Role of Pharmacists in Educating Patients About Afrezza Usage
- Understanding the Pharmacodynamics of Afrezza in Different Patient Groups
- The Role of Patient Support Programs in Afrezza Therapy Adoption
- Advances in Inhaler Technologies Inspired by Afrezza’s Design Principles
- The Role of Telemedicine in Supporting Afrezza Patients During Treatment
- Understanding the Cost-effectiveness of Afrezza for Different Patient Populations
- The Role of Healthcare Providers in Prescribing and Monitoring Afrezza Therapy
- Understanding the Legal and Prescription Requirements for Afrezza Use
- How to Transition Safely to Afrezza from Other Diabetes Medications
- Innovations in Combination Drug Formulations for Dual Therapy in Diabetic Eye Disease
- Innovative Dual Therapy Combinations Under Clinical Investigation
- The Benefits of Combining Triple Therapy with Digital Health Tools
- The Future of Triple Therapy: Emerging Drugs and Treatment Combinations
- How to Manage Potential Drug Interactions in Triple Therapy Protocols
- Innovative Delivery Methods for Triple Therapy Medications
- Addressing Patient Concerns About Polypharmacy in Triple Therapy Regimens
- Advances in Fixed Dose Combination Formulations for Enhanced Bioavailability